Julie Legrand

Julie Legrand is a seasoned professional with extensive experience in the pharmaceutical industry, particularly in oncology and immunology. At Servier from May 2018 to March 2024, Julie held several key roles, including Director of Global Business Development, R&D Director of Due Diligence, and Clinical Development Leader in Immuno-Oncology. Prior to that, from January 2011 to April 2018, Julie worked at Ipsen as a Clinical Pharmacologist specializing in Oncology and led a team focused on Immunogenicity, following a position as a Postdoctoral Researcher in the same area. Julie began a career in research at CNRS - Centre national de la recherche scientifique, where a PhD in Autoimmunity and Auto-Immune Disease was completed from September 2006 to December 2009.